|
RHEB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.104500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.156600E-01 |
| Normal-vs-Stage2 |
6.353900E-02 |
| Normal-vs-Stage3 |
9.770200E-02 |
| Normal-vs-Stage4 |
1.194780E-01 |
| Stage1-vs-Stage2 |
4.307200E-01 |
| Stage1-vs-Stage3 |
7.749400E-01 |
| Stage1-vs-Stage4 |
8.168000E-01 |
| Stage2-vs-Stage3 |
5.520200E-01 |
| Stage2-vs-Stage4 |
5.364400E-01 |
| Stage3-vs-Stage4 |
9.549200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.699800E-02 |
| Normal-vs-AfricanAmerican |
3.053000E-01 |
| Normal-vs-Asian |
3.420800E-01 |
| Caucasian-vs-AfricanAmerican |
8.908600E-01 |
| Caucasian-vs-Asian |
5.753800E-01 |
| AfricanAmerican-vs-Asian |
8.269800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.280210E-02 |
| Normal-vs-Female |
1.638750E-01 |
| Male-vs-Female |
6.704300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.875760E-01 |
| Normal-vs-Age(41-60Yrs) |
1.456180E-01 |
| Normal-vs-Age(61-80Yrs) |
4.118300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.492800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.511800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.369400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.868800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.850600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.009600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.451400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.505200E-01 |
| Classical-VS-Follicular |
2.417900E-03 |
| Classical-VS-Other |
4.832200E-01 |
| Classical-VS-Normal |
3.946000E-01 |
| Tall-VS-Follicular |
1.999620E-01 |
| Tall-VS-Other |
6.809200E-01 |
| Tall-VS-Normal |
2.208200E-01 |
| Follicular-VS-Other |
7.694800E-01 |
| Follicular-VS-Normal |
2.018900E-03 |
| Other-VS-Normal |
4.478600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.999700E-02 |
| Normal-vs-N1 |
4.636200E-02 |
| N0-vs-N1 |
8.098400E-01 |
|
|
